SM

Superluminal Medicines Inc.

Biotechnology · Boston, Massachusetts, United States

About

They combine cutting-edge structure-based drug discovery with AI-powered computational methods and experimental validation to identify and develop small molecule therapeutics. Their platform pipeline focuses on gpcrs and blends scientific innovation with patient-centric precision to develop next-generation treatments for cardiometabolic diseases.

Company details may include data from People Data Labs, licensed CC BY 4.0.